BlinkBio, Inc.
PrivateLast Round
Convertible Debt
Aug 19, 2020
Total Funding Raised
$26.7M
Company Overview
BlinkBio, Inc. is a biotechnology company that develops Tunable Drug Conjugates (TDCs) for the treatment of oncology and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BlinkBio, Inc. Comparables
Compare BlinkBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shasqi | 82% | |
| Cybrexa Therapeutics | 81% | |
| OS Therapies | 80% | |
BlinkBio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Aug 19, 2020 | ||||
| Grant | Mar 1, 2017 | ||||
| Series A | Oct 27, 2016 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 30, 2025
Monthly visitors increased 127% MoM.
- Mar 1, 2017
Secured $300K in grant funding.
BlinkBio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BlinkBio, Inc.'s valuation, stock price, and market status.